Patents Assigned to KNOTUS LIFE SCIENCE INC.
  • Pharmaceutical composition for preventing and treating obesity or liver diseases, containg TLR7 agonist
    Patent number: 10426769
    Abstract: The present invention is based on the fact that imiquimod, which is a substance that enhances Toll-like receptor 7 (TLR7) related to the innate immunity of a living body, is effective in the prevention and treatment of obesity or liver disease, and the present invention relates to a pharmaceutical composition for the prevention and treatment of obesity or liver disease, wherein the TLR7 agonist used for the immune system disease inhibits fatty acid synthetase (FAS), activates autophagosome or inhibits IGF-1.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: October 1, 2019
    Assignees: KNOTUS CO., LTD., KNOTUS LIFE SCIENCE INC.
    Inventors: Do Hyeong Kim, Sok Ho Kim, Jung Kee Kwon
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING OBESITY OR LIVER DISEASES, CONTAING TLR7 AGONIST
    Publication number: 20180161318
    Abstract: The present invention is based on the fact that imiquimod, which is a substance that enhances Toll-like receptor 7 (TLR7) related to the innate immunity of a living body, is effective in the prevention and treatment of obesity or liver disease, and the present invention relates to a pharmaceutical composition for the prevention and treatment of obesity or liver disease, wherein the TLR7 agonist used for the immune system disease inhibits fatty acid synthetase (FAS), activates autophagosome or inhibits IGF-1.
    Type: Application
    Filed: May 4, 2016
    Publication date: June 14, 2018
    Applicants: KNOTUS CO., LTD., KNOTUS LIFE SCIENCE INC.
    Inventors: Do Hyeong KIM, Sok Ho KIM, Jung Kee KWON